The reduced CYP3A4 activity that we found in morbidly obese individuals could be a result of obesity comorbidities, as lower CYP3A4 protein expression and activity have been observed in non-alcoholic fatty liver disease and diabetes25. This evidence concerns the gene CYP3A4 and obesity due to melanocortin 4 receptor deficiency.